BioWorld Asia

Jan. 22, 2003

View Archived Issues

Future Drugs Could Disrupt Protein Biosynthesis In Cancer

Procognia Closes $4M Round, Acquires Sense Proteomic Ltd.

Cyclacel Starts Phase II Trials Of Small-Molecule CDK Inhibitor

EU Leaders Support Worldwide Ban On Reproductive Cloning

ReNeuron Shares Drop On Failed Phase II Trials Of Lead Product

Second Complication Arises In French Gene Therapy Trial

Xenova Paying $1M For Rights To Two Addiction Vaccines

Adebag Planning Biotechnology Cluster In Southeastern France

Cerep Collaborates With Pfizer On BioPrint Database, Software

Other News To Note

Biolipox Raises EUR21M To Fund Drug Discovery, Development

Swedish drug discovery and development firm Biolipox AB raised €21 million in a second-round financing led by the Paris office of Apax Partners. (BioWorld International) Read More

U.S. Officials Step Up Threats Over European Ban On GM Crops

Today's news in brief

BioWorld

BioWorld briefs for July 9, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...